bupivacaine has been researched along with Marfan Syndrome, Type I in 1 studies
Bupivacaine: A widely used local anesthetic agent.
1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide : A piperidinecarboxamide obtained by formal condensation of the carboxy group of N-butylpipecolic acid with the amino group of 2,6-dimethylaniline.
bupivacaine : A racemate composed of equimolar amounts of dextrobupivacaine and levobupivacaine. Used (in the form of its hydrochloride hydrate) as a local anaesthetic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baghirzada, L | 1 |
| Krings, T | 1 |
| Carvalho, JC | 1 |
1 other study available for bupivacaine and Marfan Syndrome, Type I
| Article | Year |
|---|---|
Regional anesthesia in Marfan syndrome, not all dural ectasias are the same: a report of two cases.
Topics: Adult; Anesthesia, Conduction; Anesthesia, Epidural; Anesthetics, Local; Aorta; Apgar Score; Bupivac | 2012 |